| Code | 84045 | ||||||||||
| MA number | 59/0252/18-S | ||||||||||
| Product Form: | cps mol 50x50 mg (blis.Al/PVC) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister Al/PVC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 04.01.1996 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Sandimmun Neoral 25 mg_50 mg_cps mol_08.2023.pdf
|
| PIL: |
PIL_Sandimmun Neoral 25 mg_50 mg_cps mol_08.2023.pdf
|
| Safety feature | Yes |
| Data update: | 13.08.2018 |
